eClinical Solutions Market Poised to Reach US$ 17.9 Billion by 2028, Driven by Impressive 12.3% CAGR: IMARC Group

IMARC Group, a leading market research company, has recently released a report titled "eClinical Solutions Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028". The study provides a detailed analysis of the industry, including the market share, size, trends, and growth forecast. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

What is the market share of eClinical solutions?

The global eClinical solutions market size reached US$ 8.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 17.9 Billion by 2028, exhibiting a growth rate (CAGR) of 12.3% during 2023-2028.

Request to Get the Sample Report: https://www.imarcgroup.com/eclinical-solutions-market/requestsample

Industry Overview:

eClinical solutions refer to a suite of software applications and technologies designed to streamline and automate various aspects of clinical trials and research. These solutions encompass data collection, data management, data analysis, and reporting functionalities, with the aim of making clinical research processes more efficient and compliant with regulatory standards. They are used by pharmaceutical companies, contract research organizations (CROs), healthcare providers, and academic institutions to manage vast volumes of data generated during clinical trials. Some common eClinical solutions include electronic data capture (EDC) systems, clinical trial management systems (CTMS), electronic patient-reported outcomes (ePRO), and clinical data management systems (CDMS).

Global eClinical Solutions Market Trends:

The increasing complexity of clinical trials represents one of the key factors driving the growth of the market across the globe. Modern clinical trials are becoming more complex and data-intensive, which necessitates advanced solutions for effective data management and analysis. The rising need for compliance with stringent regulations like Good Clinical Practice (GCP) and the guidelines of the Food and Drug Administration (FDA) promotes the use of eClinical solutions for accurate data collection and auditing.

The growing concerns about data security and integrity in clinical trials are leading to the adoption of secure and validated eClinical systems. Innovations, such as cloud-based solutions, artificial intelligence (AI), and big data analytics are making eClinical solutions more efficient and versatile. Increased investments in research and development by pharmaceutical and biotechnology companies naturally drive the need for sophisticated eClinical solutions.

The shift towards patient-centric clinical trials demands real-time data collection and monitoring, which is facilitated by eClinical systems. The rising awareness about the advantages of eClinical solutions among research communities and healthcare professionals is facilitating the growth of the market across the globe.

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

• Anju Software Inc.
• Clario, Fountayn
• eClinical Solutions LLC
• eClinicalWorks
• Oracle Corporation
• PAREXEL International Corporation
• Signant Health

Speak to An Analyst: https://www.imarcgroup.com/request?type=report&id=4000&flag=C

eClinical Solutions Market Report Segmentation:

Product Insights:

• eCOA
• EDC and CDMS
• Clinical Data Integration Platforms
• Safety Solutions
• CTMS
• RTSM
• eTMF
• Clinical Analytics Platforms

Delivery Mode Insights:

• Web-hosted (On-demand)
• Licensed Enterprise (On-premises)
• Cloud-based

Development Phase Insights:

• Phase I
• Phase II
• Phase III
• Phase IV

End Use Insights:

• Hospitals
• Contract Research Organization
• Academic Institutes
• Pharma and Biotech Organizations
• Others

Regional Insights:

• North America
• Asia-Pacific
• Europe
• Latin America
• Middle East and Africa

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163

About Us: 

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.